Latest News - Medical - India - Andhra Pradesh1 - 8 of 8 press releasesDr Reddys launches Supanac® - (Diclofenac potassium)
2008-01-22, 1149 views - Dr. Reddy's Laboratories Ltd
Dr. Reddy’s has launched Supanac ® (Diclofenac potassium immediate release 50 mg tablets) in India, increasing its offering in the Rs 2700 crores (~ $688 million) NSAID market. (Source: IMS ORG June MAT ’07).
Dr Reddys announces settlement of Exelon ANDA litigation with Novartis
2008-01-22, 606 views - Dr. Reddy's Laboratories Ltd
Dr. Reddy’s announces settlement of Exelon (rivastigmine tartrate) ANDA litigation with Novartis
Argenta Discovery and Dr Reddy’s progress pre-clinical anti-inflammatory candidates
2007-12-20, 243 views - Dr.Reddy's Laboratories Ltd.
Argenta Discovery Limited, the respiratory drug discovery and development company, and Dr Reddy’s Laboratories (NYSE: RDY), today announce a major milestone in their development programme
SYGNIS AG and DR REDDYS Pharmaceutical Company sign exclusive supply collaboration for AX200
2007-12-20, 333 views - Dr.Reddy's Laboratories Ltd.
-- Agreement with Dr. Reddy’s secures long-term supply to advance the clinical development of SYGNIS’ lead product candidate -- -- Dr. Reddy’s first agreement for the long-term supply of a biological molecule; First of its kind from India --
Dr.Reddy’s Pharmaceutical Company Q2 FY08 revenue at Rs 12,670 million
2007-11-15, 353 views - Dr.Reddy's Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its unaudited financial results for the quarter ended September 30, 2007.
Dr. Reddy'S Pharmaceutical Company Annual Report on form 20-F for year ended March 31, 2007
2007-10-10, 497 views - Dr.Reddy's Laboratories Ltd
Dr. Reddy’s Laboratories Limited (NYSE: RDY) announces that the company’s annual report on Form 20-F for the year ended March 31, 2007 is available on its website ( http://www.drreddys.com )
Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines.
2007-10-10, 1064 views - Dr.Reddy's Pharmaceutical Company
Dr. Reddy's Pharmaceutical Company Commences Operations in Philippines. Expands presence in the ASEAN region
Dr. Reddys receives USFDA approval for Ranitidine (Zantac™) Tablets, 150mg (OTC)
2007-09-17, 352 views - Dr.Reddy's Laboratories Ltd
Dr. Reddy’s Laboratories (NYSE:RDY) announced today, that the U.S. Food and Drug Administration (USFDA) has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) for Ranitidine (Zantac™) 150mg tablet.
| 
Medical